Full access to all news articles, including in-depth analysis and opinion pieces.
Exclusive interviews with experts and influential figures.
Enhanced multimedia experience with videos, photo galleries, and interactive graphics.
Ad-free browsing for a seamless reading experience.
Global Insights
$
$
9.99
$
0
/ 30 days
/ 30 days
placeholder text
Global Insights Subscription:
All features of the Premium Subscription.
Exclusive access to monthly webinars or live Q&A sessions with our journalists and correspondents, providing insights into the news-gathering process and global events.
Customizable news alerts tailored to your specific interests and regions.
Early access to special investigative reports and in-depth features.
Neurotech start-up Paradromics will be trialing its brain implant next year, as the race to be the leader in the nascent brain-computer interface (BCI) space heats up."The brain is...
In this photo illustration, UnitedHealth Group Inc logo seen displayed on a tablet.Igor Golovniov | Sopa Images | Lightrocket | Getty ImagesChange Healthcare on Friday said it's finished setting...
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March...